2012
DOI: 10.1039/c2nj40165g
|View full text |Cite
|
Sign up to set email alerts
|

Characteristics of complexes between poly(propylene imine) dendrimers and nucleotides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
25
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
5
1

Relationship

3
3

Authors

Journals

citations
Cited by 13 publications
(28 citation statements)
references
References 34 publications
(68 reference statements)
3
25
0
Order By: Relevance
“…Our scientific interests have concentrated on the possibility of using so‐called open‐shell (OS) poly(propyleneimine) (PPI) dendrimers with their surfaces partially coated with maltose units for the intracellular delivery of active triphosphate forms of adenosine analogues. Such glycodendrimers exhibit high biocompatibility as well as the capacity to form stable complexes with nucleoside triphosphates and to protect them from enzymatic degradation . We proved that the fourth generation maltose‐modified PPI dendrimer (PPI‐Mal OS G4) can serve as an efficient nanocarrier for an active metabolite of fludarabine (Ara‐FATP), increasing its cytotoxic activity and overcoming NT‐associated resistance due to the independent mechanism of cell entry …”
Section: Zeta Potential Of Ppi Dendrimers and Nucleotide–dendrimer Comentioning
confidence: 98%
“…Our scientific interests have concentrated on the possibility of using so‐called open‐shell (OS) poly(propyleneimine) (PPI) dendrimers with their surfaces partially coated with maltose units for the intracellular delivery of active triphosphate forms of adenosine analogues. Such glycodendrimers exhibit high biocompatibility as well as the capacity to form stable complexes with nucleoside triphosphates and to protect them from enzymatic degradation . We proved that the fourth generation maltose‐modified PPI dendrimer (PPI‐Mal OS G4) can serve as an efficient nanocarrier for an active metabolite of fludarabine (Ara‐FATP), increasing its cytotoxic activity and overcoming NT‐associated resistance due to the independent mechanism of cell entry …”
Section: Zeta Potential Of Ppi Dendrimers and Nucleotide–dendrimer Comentioning
confidence: 98%
“…Recently, our studies showed that cationic poly(propylene imine) dendrimers and hyperbranched poly(ethylene imine)s (PEI) decorated with oligosaccharide shells are suitable materials to complex anionic analyte molecules (e.g., ATP,13, 14 Mant‐ATP,15 Rose Bengal16 and nucleic acids17, 18). Physico‐chemical and molecular modelling studies confirmed the core–shell architectures of these dendritic glycopolymers 19.…”
Section: Number Of Each Type Of Analyte Molecule Complexed Per Macrommentioning
confidence: 99%
“…Thus, the buffer and ionic strength of these complexation conditions significantly influence the complexation capability of the PEI‐OS architectures under the defined conditions. In this context, the different interaction features of dense‐ and open‐shell glycodendrimers with ATP and Mant‐ATP, determined in water and PBS buffer, have been described, wherein the influence of the oligosaccharide architecture and the PBS buffer was evaluated 14. 15…”
Section: Number Of Each Type Of Analyte Molecule Complexed Per Macrommentioning
confidence: 99%
“…In recent studies [19][20][21][22][23], the coupling of mono-and oligosaccharide units has successfully been accomplished. Hence, these dendritic glycoarchitectures have been considered as nanocarriers for drugs [19,20,23]. For instance, dendritic glycoarchitectures based on PEI core [19,23] outlines enhanced biocompatibility and reduced cytotoxicity compared with the bare hyperbranched PEI.…”
Section: Introductionmentioning
confidence: 98%
“…Though an enhancement of biocompatibility can be achieved through the incorporation of water-soluble and biocompatible surface groups in the outer shell of the dendritic architecture consisting of poly(propylene imine) (PPI) dendrimers, poly(amido amine) (PAMAM) dendrimers, hyperbranched poly(ethylene imine) (PEI), and other dendritic scaffolds [13][14][15][16][17][18]. In recent studies [19][20][21][22][23], the coupling of mono-and oligosaccharide units has successfully been accomplished. Hence, these dendritic glycoarchitectures have been considered as nanocarriers for drugs [19,20,23].…”
Section: Introductionmentioning
confidence: 99%